HIV-1 suppression and rare dolutegravir resistance in antiretroviral-experienced people with HIV in Liberia.

Journal: Communications medicine
Published Date:

Abstract

BACKGROUND: Increasingly, persons with HIV in Liberia are receiving antiretroviral therapy containing the integrase strand-transfer inhibitor (InSTI) dolutegravir (DTG), but the prevalence of and factors associated with virologic failure and HIV drug resistance (HIVDR) remain unknown.

Authors

  • James Soka Moses
    Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia. SMoses@prevailcr.org.
  • Alice K Pau
    National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Safia Kuriakose
    Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Greg Grandits
    Division of Biostatistics, School of Public health, University of Minnesota, Minneapolis, MN, USA.
  • Cavan Reilly
    Division of Biostatistics, School of Public health, University of Minnesota, Minneapolis, MN, USA.
  • Brad T Sherman
    Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Weizhong Chang
    Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Lisheng Dai
    Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Muhammad A Khan
    Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Helene Highbarger
    Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Moses Mannah
    Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Johnathan McCullough
    Advanced BioMedical Laboratories, LLC, Cinnaminson, NJ, USA.
  • Carla Chorley
    Clinical Monitoring Research Program Directorate (CMRPD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Isaac Morlu
    Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Joseph Dorbor
    Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Ophelia Talweh Bongolee
    Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Rebecca Slewion
    Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Esther Akpa
    Clinical Monitoring Research Program Directorate (CMRPD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Barthalomew Wilson
    Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • April L Poole
    National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Stacy L Kopka
    Clinical Monitoring Research Program Directorate (CMRPD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Tracey Miller
    Clinical Monitoring Research Program Directorate (CMRPD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Cecelia J Nuta
    John F. Kennedy Medical Center, Monrovia, Liberia.
  • Christina Lindan
    University of California San Francisco, San Francisco, CA, USA.
  • David Glidden
    University of California San Francisco, San Francisco, CA, USA.
  • Jeffrey N Martin
    Departments of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California, USA.
  • Kumblytee L Johnson
    Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Robin L Dewar
    Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Ian Wachekwa
    Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Stephen A Migueles
    National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.

Keywords

No keywords available for this article.